HPLC evaluation of diclofenac in transdermal therapeutic preparations

Citation
J. Klimes et al., HPLC evaluation of diclofenac in transdermal therapeutic preparations, INT J PHARM, 217(1-2), 2001, pp. 153-160
Citations number
18
Categorie Soggetti
Pharmacology & Toxicology
Journal title
INTERNATIONAL JOURNAL OF PHARMACEUTICS
ISSN journal
03785173 → ACNP
Volume
217
Issue
1-2
Year of publication
2001
Pages
153 - 160
Database
ISI
SICI code
0378-5173(20010417)217:1-2<153:HEODIT>2.0.ZU;2-S
Abstract
High-performance liquid chromatography (HPLC) was selected for analytical e valuation of sodium diclofenac in original transdermal therapeutic preparat ions containing adjuvant substances (capsaicin, hyoscyamine). After isolati on from laminated adhesive patches, diclofenac was analysed on columns with reversed phase, using the mobile phase ethanol and phosphate buffer (pH 6. 5) with an addition of tetrabutylammonium iodide and detection at 284 nm. N ot only the total amount of diclofenac in the patch was evaluated, but HPLC methodology was also employed to select a suitable acceptor medium for per meation experiments. In patches manufactured in the tested series, HPLC was also employed to examine the release of diclofenac and its in vitro permea tion through the human skin. (C) 2001 Elsevier Science B.V. All rights rese rved.